<DOC>
	<DOCNO>NCT02183272</DOCNO>
	<brief_summary>The objective current program research test whether intranasal ketamine treatment effective placebo reduce suicidal ideation suicidal patient present acute treatment emergency department setting . Secondary objective test effect genotypic difference mu opioid receptor efficacy ketamine correlation speech pattern facial movement pattern subjective reduction suicidal ideation ketamine treatment .</brief_summary>
	<brief_title>Emergency Ketamine Treatment Suicidal Ideation</brief_title>
	<detailed_description>The objective current program research test whether intranasal ketamine treatment effective placebo reduce suicidal ideation suicidal patient present acute treatment emergency department setting . Secondary objective test effect genotypic difference mu opioid receptor efficacy ketamine correlation speech pattern facial movement pattern subjective reduction suicidal ideation ketamine treatment</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Emergencies</mesh_term>
	<mesh_term>Suicidal Ideation</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<criteria>1 . Males females 2 . Ages 1865 3 . All race ethnicities 4 . Willing able provide inform consent 5 . A cutoff score &gt; 3 Beck Scale Suicidal Ideation 6 . &gt; 2 Columbia Scale Suicide Severity Rating 1 . Pregnancy lactation ; woman reproductive potential must negative urine pregnancy test 2 . Postpartum state ( within 2 month delivery ) 3 . Homicide risk determine clinical interview 4 . Any following Diagnostic Statistical Manual Mental Disorders ( DSMIV ) diagnose : 1 . Any current primary psychotic disorder 2 . Acute intoxication withdrawal alcohol substance abuse , determine clinical interview urine drug screen except opioids 3. use hallucinogen ( except cannabis ) , last month 4 . Any dissociative disorder 5 . Pervasive developmental disorder 6 . Cognitive disorder 7 . Cluster A personality disorder 8 . Anorexia nervosa . 5 . Treatment medication know affect NmethylDaspartate ( NMDA ) receptor system ( e.g. , lamotrigine , acamprosate , memantine , riluzole , lithium ) 6 . Any known hypersensitivity serious adverse effect ketamine 7 . Any clinicallysignificant medication condition would preclude use ketamine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Depression</keyword>
	<keyword>Suicidal Ideation</keyword>
	<keyword>Ketamine</keyword>
	<keyword>Emergency Department</keyword>
</DOC>